|

anti-CD70-CAR-T cells Clinical Trials

2 actively recruiting trials

Pipeline

Early 1: 1Phase 1: 1

Top Sponsors

  • Shanghai Changzheng Hospital1
  • Changhai Hospital1

Indications

  • Cancer2
  • CD70-positive Advanced Urologic Neoplasms1
  • Renal Cell Carcinoma1

Other2 trials

Anti-CD70 CAR-T Cell Injection in Patients With CD70-positive Advanced Urologic Neoplasms
Phase 1
Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.